The Brazil IP office president’s efforts to reduce one of the world’s worst backlogs have been derailed by recession. However, he hopes to take proactive measures, despite sceptical IP practitioners inside and outside Brazil and the controversy over double examination of pharmaceutical patents. Michael Loney reports
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
A&O Shearman and Fish & Richardson invested in German talent, meanwhile, major firms have assembled for an on the merits case pitting KeeeX against OpenAI and Adobe